Sprycel® (Dasatinib)

Sprycel® (Dasatinib)

What is SPRYCEL? SPRYCEL® (dasatinib) is a prescription medicine used to treat: adults with newly diagnosed Philadelphia chromosome–positive (Ph+) chronic myeloid leukemia (CML) in chronic phase (CP), adults with Ph+ CML who no longer benefit from, or did not tolerate, other treatment, including imatinib, adults with Ph+ acute lymphoblastic leukemia (Ph+ ALL) who no longer benefit from, or did not tolerate, other treatment, children 1 year of age and older with Ph+ CML in chronic phase, and children 1 year of age and older with newly diagnosed Ph+ ALL in combination with chemotherapy.